| Literature DB >> 32578709 |
Susana Eulalia Dueñas Matute1,2, Eduardo Antônio Donadi2, Altacílio Aparecido Nunes2, Edson Zangiacomi Martinez2.
Abstract
INTRODUCTION: Community-acquired pneumonia (CAP) is an important cause of morbidity and mortality worldwide. This study compares the clinical response to antimicrobials between indigenous and non-indigenous Kichwa children under 5 years old with CAP in Otavalo, Ecuador.Entities:
Year: 2020 PMID: 32578709 PMCID: PMC7310356 DOI: 10.1590/0037-8682-0038-2020
Source DB: PubMed Journal: Rev Soc Bras Med Trop ISSN: 0037-8682 Impact factor: 1.581
Participant characteristics by ethnic group.
| Indigenous | Non-indigenous | Total | P value | ||||
|---|---|---|---|---|---|---|---|
| (n = 72) | (n = 34) | (N = 106) | |||||
| n | % | n | % | n | % | (a) | |
|
| 0.20 | ||||||
| Male | 48 | 66.7 | 18 | 52.9 | 66 | 62.3 | |
| Female | 24 | 33.3 | 16 | 47.1 | 40 | 37.7 | |
|
| 0.63 | ||||||
| Infant | 43 | 59.7 | 17 | 50.0 | 60 | 56.6 | |
| Toddler | 21 | 29.2 | 12 | 35.3 | 33 | 31.1 | |
| Preschool | 8 | 11.1 | 5 | 14.7 | 13 | 12.3 | |
|
| 0.50 | ||||||
| Adequate | 63 | 87.5 | 32 | 94.1 | 95 | 89.6 | |
| Inadequate | 9 | 12.5 | 2 | 5.9 | 13 | 10.4 | |
|
| 0.05 | ||||||
| Hospital | 64 | 88.9 | 34 | 100.0 | 98 | 92.5 | |
| House | 8 | 11.1 | 0 | 0.0 | 8 | 7.5 | |
|
| |||||||
| Rural | 52 | 72.2 | 13 | 38.2 | 65 | 61.3 | |
| Urban | 20 | 27.8 | 21 | 61.8 | 41 | 38.7 | |
|
| 0.51 | ||||||
| 6 months | 27 | 37.5 | 9 | 26.5 | 36 | 34.0 | |
| 12 months | 27 | 37.5 | 16 | 47.1 | 43 | 40.6 | |
| 24 months | 18 | 25.0 | 9 | 26.5 | 27 | 25.0 | |
|
| 1.00 | ||||||
| Complete | 56 | 77.8 | 27 | 79.4 | 83 | 78.3 | |
| Incomplete | 16 | 22.2 | 7 | 20.6 | 23 | 21.7 | |
|
| 1.00 | ||||||
| No | 4 | 5.6 | 2 | 5.9 | 6 | 5.7 | |
| Yes | 68 | 94.4 | 32 | 94.1 | 100 | 94.3 | |
|
| <0.01 | ||||||
| No | 30 | 41.7 | 24 | 70.6 | 54 | 50.9 | |
| Yes | 42 | 58.3 | 10 | 29.4 | 52 | 49.1 | |
(a) Fisher´s exact test.
Clinical responses by ethnic group.
| Indigenous | Non-indigenous | Total | P value | ||||
|---|---|---|---|---|---|---|---|
| (n = 72) | (n = 34) | (N = 106) | |||||
| n | % | n | % | n | % | (a) | |
|
| 1.00 | ||||||
| Alive | 71 | 98.6 | 34 | 100.0 | 105 | 99.1 | |
| Dead | 1 | 1.4 | 0 | 0.0 | 1 | 0.9 | |
|
| 0.26 | ||||||
| None | 1 | 1.4 | 0 | 0.0 | 1 | 0.9 | |
| First-generation (b) | 24 | 33.3 | 12 | 35.3 | 37 | 34.9 | |
| Second-generation (c) | 12 | 16.7 | 11 | 32.4 | 22 | 20.8 | |
| Third-generation (d) | 11 | 15.3 | 4 | 11.8 | 16 | 15.1 | |
| Double combination | 13 | 18.1 | 6 | 17.6 | 24 | 22.6 | |
| Triple combination | 11 | 15.3 | 1 | 2.9 | 6 | 5.7 | |
|
| 0.60 | ||||||
| ≤6 days | 57 | 79.2 | 29 | 85.3 | 86 | 81.1 | |
| >6 days | 15 | 20.8 | 5 | 14.7 | 20 | 18.9 | |
|
| 0.03 | ||||||
| Yes | 29 | 40.3 | 12 | 35.3 | 41 | 38.7 | |
| No | 35 | 48.6 | 11 | 32.4 | 46 | 43.4 | |
| Unknown | 8 | 11.1 | 11 | 32.4 | 19 | 17.9 | |
(a) Fisher´s exact test; (b) ampicillin or gentamicin; (c) ampicillin plus sulbactam, or amoxicillin plus clavulanic acid; (d) ceftriaxone or cefotaxime.